Sensei Biotherapeutics, Inc.

NASDAQ:SNSE

0.5004 (USD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -34.101-48.588-36.794-20.1-16.74-13.039
Depreciation & Amortization 0.5711.3470.6850.2090.0730.044
Deferred Income Tax 2.33100.019-1.041.9730
Stock Based Compensation 4.4545.8125.6571.4921.1761.192
Change In Working Capital -4.331.0080.117-0.3973.4691.49
Accounts Receivables 000000
Inventory 000000
Accounts Payables -2.3312.017-1.4260.3352.3420.931
Other Working Capital -1.999-1.0091.543-0.7321.1270.559
Other Non Cash Items -0.9481.3950.0572.1311.4780.349
Operating Cash Flow -32.023-39.026-30.259-17.705-8.571-10.313
Investing Activities:
Investments In Property Plant And Equipment -0.18-0.321-2.026-1.206-0.053-0.031
Acquisitions Net 0.1660.0150.318-0.19700
Purchases Of Investments -21.149-46.869-183.669000
Sales Maturities Of Investments 59.57597.12442.259000
Other Investing Activites 0.0390.05-0.141-0.19700
Investing Cash Flow 38.41249.949-143.118-1.403-0.053-0.031
Financing Activities:
Debt Repayment -0.761-0.629-0-0.041-0.027-0.75
Common Stock Issued 0.0480.238164.1150.5410.1540
Common Stock Repurchased -10.38400000
Dividends Paid 000000
Other Financing Activities -0.0760.1040.16434.9538.0950.75
Financing Cash Flow -11.173-0.2870.16435.4538.2220.75
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -4.78410.636-9.43716.345-0.402-9.594
Cash At End Of Period 13.01117.7957.15916.5960.2510.653